NYSE Takes Action Against FiscalNote and BiomX Over Listing Non-Compliance

Key Facts

The New York Stock Exchange (NYSE) has initiated delisting proceedings for FiscalNote Holdings (NOTE), immediately suspending its Class A common stock and warrants. NYSE Regulation determined that FiscalNote no longer meets the suitability standards for continued listing on the exchange. Simultaneously, BiomX Inc. has received a deficiency notification from NYSE American regarding its stockholders' equity levels, which have fallen below required thresholds. The auditor's report for BiomX further highlighted financial risks, including a 'Going Concern' explanatory paragraph regarding its future viability. These developments underscore the heightened regulatory scrutiny on companies failing to maintain minimum financial and market capitalization requirements. Both firms now face potential transitions to over-the-counter (OTC) markets, which typically results in significantly reduced trading liquidity for investors.